Burden of esophageal cancer in Iran during 1995-2015: Review of findings from the Global Burden of Disease studies

Rahmani, Hojjat; Asiabar, Ali Sarabi; Niakan, Somayeh; Hashemi, Seyed Yaser; Faramarzi, Ahmad; Manuchehri, Sahar; Vasokolaei, Ghasem Rajabi

doi:10.14196/mjiri.32.55

Cited by 17 publications

(14 citation statements)

References 25 publications

(22 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Contrast, the results of the study suggested that our estimated DALY rates were substantially higher than in many other countries including developing and developed countries [19,21]. For example, the DALY rates per 100 000 people were predicted to about 120 in males and 68 in females in 2015 in Iran, while in the United Kingdom and Japan, it was 88 and 69 in both-sex respectively 2008 [21].…”

Section: Ec Disease Prevalencecontrasting

confidence: 63%

See 1 more Smart Citation

Article The Burden of Esophageal Cancer in China From 2013 to 2030 A Dynamic Cohort Modeling Study

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: This study aimed to predict the disease burden of esophageal cancer (EC) over the period 2013-2030 in China. Methods : A dynamic cohort Markov model was developed to simulate the EC prevalence, disability-adjusted life years (DALY), and the medical direct expenditure based on gender. JoinPoint Regression Program was used to calculate the average annual percentage change (AAPC) of EC prevalence and DALY rates, while the regression model was applied to analyze the changing trend of economic burden over time. Results: The predicted DALY rates per 100 000 people increased in both-sex (219.17 - 252.39) and males (302.89 – 384.31), while it decreased in females (131.21- 115.91). The years of life lost (YLL) accounted for the majority of DALYs. The AAPC were 0.8%(95% CI, 0.8%-0.9%), 1.4%(95% CI, 1.3%- 1.5%), and -0.7%(95% CI, -0.8%- -0.7%) in both-sex, males and females, respectively. The medical direct expenditure in both-sex, males, and females was predicted to increase by 165.35%, 194.04%, and 94.20%, respectively. Conclusions: EC still caused a severe burden on society. YLL was responsible for the majority of the DALYs, which highly suggesting the implementation of accurate prevention like screening and early diagnosis and treatment programs.

show abstract

Section: Ec Disease Prevalencecontrasting

confidence: 63%

“…Our study demonstrated that the burden of EC was higher in males. The main reason may be that males were more exposed to risk factors such as tobacco and alcohol consumption [19].…”

Section: Ec Disease Prevalencementioning

confidence: 99%

Article The Burden of Esophageal Cancer in China From 2013 to 2030 A Dynamic Cohort Modeling Study

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Owing to broad array of data sources and scientific statistical modeling approaches (15,16), GBD study can provide comprehensive estimates of CKD-DM burden to date. GBD 2019 study includes 369 diseases and injuries data in 204 countries and territories (4,10).…”

Section: Introductionmentioning

confidence: 99%

Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019

Deng

et al. 2021

Front. Endocrinol.

139

View full text Add to dashboard Cite

BackgroundChronic kidney disease (CKD) is a public health problem largely caused by diabetes. The epidemiology of diabetes mellitus–related CKD (CKD-DM) could provide specific support to lessen global, regional, and national CKD burden.MethodsData were derived from the GBD 2019 study, including four measures and age-standardized rates (ASRs). Estimated annual percentage changes and 95% CIs were calculated to evaluate the variation trend of ASRs.ResultsDiabetes caused the majority of new cases and patients with CKD in all regions. All ASRs for type 2 diabetes–related CKD increased over 30 years. Asia and Middle socio-demographic index (SDI) quintile always carried the heaviest burden of CKD-DM. Diabetes type 2 became the second leading cause of CKD and CKD-related death and the third leading cause of CKD-related DALYs in 2019. Type 2 diabetes–related CKD accounted for most of the CKD-DM disease burden. There were 2.62 million incident cases, 134.58 million patients, 405.99 thousand deaths, and 13.09 million disability-adjusted life-years (DALYs) of CKD-DM worldwide in 2019. Age-standardized incidence (ASIR) and prevalence rate (ASPR) of type 1 diabetes–related CKD increased, whereas age-standardized death rate (ASDR) and DALY rate decreased for females and increased for males. In high SDI quintile, ASIR and ASPR of type 1 diabetes–related CKD remained the highest, with the slowest increase, whereas the ASDR and age-standardized DALY rate remained the lowest there. In high SDI quintile, ASIR of type 2 diabetes–related CKD was the highest, with the lowest increasing rate. In addition, type 2 diabetes–related CKD occurred most in people aged 80-plus years worldwide. The main age of type 2 diabetes–related CKD patients was 55–64 years in Asia and Africa. The prevalence, mortality, and DALY rate of type 2 diabetes–related CKD increased with age. As for incidence, there was a peak at 80 years, and after age of 80, the incidence declined. CKD-DM-related anemia was mainly in mild to moderate grade.ConclusionsIncreasing burden of CKD-DM varied among regions and countries. Prevention and treatment measures should be strengthened according to CKD-DM epidemiology, especially in middle SDI quintile and Asia.

show abstract

“…The remaining knowledge gap can be filled by a systematic evaluation of available data from the Global Burden of Disease (GBD) database that can provide an opportunity for timely and transparent estimates of disease incidence, mortality, DALY, and other metrics to describe the disease burden at the geographic scales of global, regional, and national levels. So far, a large number of articles using the GBD database have been published and serve to improve health policies (10)(11)(12).…”

Section: Introductionmentioning

confidence: 99%

Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017

Wang

Wei

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Objective: The global trends in myocarditis burden over the past two decades remain poorly understood and might be increasing during the coronavirus disease 2019 (COVID-19) worldwide pandemic. This study aimed to provide comprehensive estimates of the incidence, mortality, and disability-adjusted life years (DALYs) for myocarditis globally from 1990 to 2017.Methods: Data regarding the incidence, mortality, DALY, and estimated annual percentage change (EAPC) between 1990 and 2017 for myocarditis worldwide were collected and calculated from the 2017 Global Burden of Disease study. We additionally calculated the myocarditis burden distribution based on the Socio-Demographic Index (SDI) quintile and Human Development Index (HDI).Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. The number of deaths due to myocarditis increased gradually from 27,120 in 1990 to 46,490 in 2017. The middle SDI quintile showed the highest number of myocarditis-related deaths. On the contrary, the global age-standardized death rate (ASDR) decreased with an overall EAPC of −1.4 [95% uncertainty interval (UI) = −1.8 to −1.0]. Similar to ASDR, the global age-standardized DALY rate also declined, with an EAPC of −1.50 (95% UI = −2.30 to −0.8) from 1990 to 2017. However, there was a 12.1% increase in the number of DALYs in the past 28 years; the middle SDI and low-middle SDI quintiles contributed the most to the DALY number in 2017. We also observed significant positive correlations between the EPAC of age-standardized rate and HDI for both death and DALY in 2017.Conclusions: Globally, the ASIR, ASDR, and age-standardized DALY rate of myocarditis decreased slightly from 1990 to 2017. The middle SDI quintile had the highest level of ASIR, ASDR, and age-standardized DALY rate, indicating that targeted control should be developed to reduce the myocarditis burden especially based on the regional socioeconomic status. Our findings also provide a platform for further investigation into the myocarditis burden in the era of COVID-19.

show abstract

Burden of esophageal cancer in Iran during 1995-2015: Review of findings from the Global Burden of Disease studies

Cited by 17 publications

References 25 publications

Article The Burden of Esophageal Cancer in China From 2013 to 2030 A Dynamic Cohort Modeling Study

Article The Burden of Esophageal Cancer in China From 2013 to 2030 A Dynamic Cohort Modeling Study

Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019

Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017

Contact Info

Product

Resources

About